Enterol(Ultra Levure)
Saccharomyces boulardiiCNCM I-745
Enterol and Ultra Levure are different trade names for the same medicine.
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Enterol is an oral anti-diarrheal medicine, whose active substance is lyophilized Saccharomyces boulardiiyeast, classified as probiotics, i.e., living microorganisms that provide health benefits to the host organism.
The intestinal bacterial flora consists of billions of microorganisms. Maintaining the balance of the intestinal microflora is essential for ensuring the proper functioning of the digestive tract, such as:
digestion, resistance to infections, and strengthening the natural immune system.
The balance of the bacterial flora is delicate and can be disrupted by many factors:
gastrointestinal infections, both viral and bacterial, taking certain medications, including antibiotics, changes in dietary habits. This can lead to a range of digestive problems resulting in diarrhea.
Enterol is a medicine that affects the intestinal flora, a so-called "natural flora substitute," which allows for the temporary disruption of the balance to be restored.
Enterol is used in:
If there is no improvement after 2 days or the patient feels worse, they should consult their doctor.
Before starting to take Enterol, the patient should discuss it with their doctor or pharmacist.
It is not recommended to open capsules near patients with a central venous catheter to prevent unwanted fungal colonization of the catheter, especially through contaminated hands. There have been reports of very rare cases of fungemia (fungal penetration into the blood) with accompanying fever and positive blood culture results, even in patients not treated with Saccharomyces boulardii. In all reported cases, fungemia resolved after antifungal treatment or, if necessary, after removal of the central venous catheter.
As a supplement to treatment, it is recommended:
The patient should immediately consult their doctor if:
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Enterol should not be taken simultaneously with oral antifungal medicines (medicines used to treat fungal infections).
Enterol contains live cells. Therefore, it should not be mixed with very hot (above 50°C) or cold liquids, foods, or alcohol, as this could destroy the yeast cells.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Due to the lack of data, it is not recommended to take the medicine during pregnancy.
Saccharomyces boulardiiis not absorbed into breast milk. Due to the lack of data, it is recommended to consider the benefit-risk ratio before taking Enterol during breastfeeding.
The medicine does not affect driving or operating machines.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist.
Recommended dosage for adults and children:
acute infectious diarrhea: 1 to 2 capsules per day for up to 1 week
antibiotic-associated diarrhea: 1 to 2 capsules per day during and after antibiotic therapy
diarrhea caused by C. difficileinfection: 4 capsules per day for up to 4 weeks
diarrhea associated with enteral nutrition: 1 to 2 capsules per day
traveler's diarrhea: 1 to 4 capsules per day for up to 1 week
supportive treatment of diarrhea in irritable bowel syndrome (IBS): 1 capsule 1 to 2 times a day. Diarrhea treatment should be continued for several days after symptoms have resolved.
Method of administration:
Take orally. The capsule should be swallowed with a glass of water.
The capsule can be opened, and its contents poured into a small amount of sweetened drink, food, or added to a baby's bottle.
In children under 6 years of age, it is not recommended to take capsules due to the risk of choking; it is recommended to open the capsules and add their contents to a drink or food.
A double dose should not be taken to make up for a missed dose.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Enterol can cause side effects, although not everybody gets them.
Rare (occurring in less than 1 in 1000 patients): a few cases of bloating have been reported.
Very rare (occurring in less than 1 in 10,000 patients): local rash, allergic reactions, urticaria, itching, anaphylactic reactions, facial swelling, angioedema, rash all over the body (exanthema), fungal penetration into the blood (fungemia).
Frequency not known (frequency cannot be estimated from the available data): constipation, severe blood infection (sepsis).
If the patient experiences any side effects, including those not listed in the leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Store in a temperature below 25°C. Protect from moisture.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White hard capsules containing light brown powder with a characteristic odor.
A glass bottle (type III) with a plastic cap, in a cardboard box, containing 10 hard capsules.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Petsiavas A.E.
Ag. Anargyron 21
145 64 K. Kifissia
Greece
BIOCODEX
1 avenue Blaise Pascal
60000 BEAUVAIS
France
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing Authorization Number in Greece, the Country of Export:67617/22-6-2018
54567/23-06-2021
[Information about the Trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.